A case of VIPoma

Int J Obstet Anesth. 2022 Nov:52:103600. doi: 10.1016/j.ijoa.2022.103600. Epub 2022 Sep 28.

Abstract

This case report addresses the management of a pregnant woman in the peripartum period with a VIPoma. This rare and highly malignant neuroendocrine tumour secretes vasoactive intestinal peptide (VIP), a substance that may cause potentially life-threatening disruption to physiology. A 36-year-old woman presented for induction of labour with a three-year history of chronic diarrhoea, hypophosphataemia, palpitations and skin flushing. Raised VIP levels indicated presence of a VIPoma, however despite extensive investigation prior to pregnancy by neuroendocrine specialists, the tumour location remained unidentified. The patient delivered a healthy boy with the aid of forceps in theatre following an epidural top-up. Key features of management were a multidisciplinary approach, avoidance of triggers for VIP secretion, strict management of electrolytes and avoidance of severe changes in sympathetic tone during labour with epidural analgesia.

Keywords: Neuroendocrine tumour; Pregnancy; VIPoma.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Female
  • Humans
  • Male
  • Pancreatic Neoplasms*
  • Pregnancy
  • Vasoactive Intestinal Peptide
  • Vipoma* / pathology

Substances

  • Vasoactive Intestinal Peptide